Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Do Young Kim

Showing results (1-10 of 919) with videos related to

Pageof 92
Sort By:
The Korean Journal of Hepatology|March 19, 2011
Which treatment modality should we choose for advanced hepatocellular carcinoma?Do Young Kim
Gut and Liver|March 17, 2020
Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus?Do Young Kim
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|January 29, 2019
[New Systemic Therapies for Advanced Hepatocellular Carcinoma]Do Young Kim
Clinical and Molecular Hepatology|July 3, 2017
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?Do Young Kim
Clinical and Molecular Hepatology|June 24, 2022
Erratum to 'History and future of hepatitis B virus control in South Korea' [Clin Mol Hepatol 2021;27:620-622]Do Young Kim
Gut and Liver|November 24, 2018
Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real PracticeDo Young Kim
Journal of Liver Cancer|March 25, 2024
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwideDo Young Kim
Clinical and Molecular Hepatology|September 23, 2021
History and future of hepatitis B virus control in South KoreaDo Young Kim
The British Journal of Dermatology|March 12, 2024
Mortality landscape of Behçet diseaseDo-Young Kim
Gut and Liver|October 31, 2017
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral TherapyDo Young Kim
Pageof 92

Showing results (1-10 of 919) with videos related to

Sort By:
Pageof 92
The Korean Journal of Hepatology|March 19, 2011
Which treatment modality should we choose for advanced hepatocellular carcinoma?Do Young Kim
Gut and Liver|March 17, 2020
Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus?Do Young Kim
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|January 29, 2019
[New Systemic Therapies for Advanced Hepatocellular Carcinoma]Do Young Kim
Clinical and Molecular Hepatology|July 3, 2017
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?Do Young Kim
Clinical and Molecular Hepatology|June 24, 2022
Erratum to 'History and future of hepatitis B virus control in South Korea' [Clin Mol Hepatol 2021;27:620-622]Do Young Kim
Gut and Liver|November 24, 2018
Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real PracticeDo Young Kim
Journal of Liver Cancer|March 25, 2024
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwideDo Young Kim
Clinical and Molecular Hepatology|September 23, 2021
History and future of hepatitis B virus control in South KoreaDo Young Kim
The British Journal of Dermatology|March 12, 2024
Mortality landscape of Behçet diseaseDo-Young Kim
Gut and Liver|October 31, 2017
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral TherapyDo Young Kim
Pageof 92